|
|
|
|
Immunohistochemical Expression of Glypican-3 in Pediatric Tumors: An Analysis of 414 Cases. <<view abstract in PubMed >> Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression >> Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms >>
|
Positive glypican-3 expression in early hepatocellular carcinoma
predicts recurrence after hepatectomy
<<view abstract in PubMed >>  Copyright 2013 - BioMosaics Inc. 655 Spear St. Building C, Burlington, VT 05405 - +1 877 742-2066
Welcome to BioMosaics BioMosaics is a biomarker development company. We commercialize assays and reagents for the early detection of cancer, for use in clinical and research settings. In addition to our antibody products for clinical immunohistochemistry, we are developing novel oncology immunoassays for tumor markers, as well as assays for detection of DNA damage and somatic mutation.
MCJ/DnaJC15, an endogenous mitochondrial repressor of the
respiratory chain that controls metabolic alterations.
<<view
abstract in PubMed >>
Methylation-controlled J-protein MCJ acts in the import of proteins into human mitochondria <<view abstract in PubMed >> |
